Groowe Groowe / Newsroom / BNTX
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

BNTX News

BioNTech SE American Depositary Share

Bavarian Nordic Receives European Commission Approval of Mpox/Smallpox Vaccine for Children Aged 2 to Less than 12 Years

globenewswire.com
BNTX

BioNTech Announces Second Quarter 2026 Financial Results and Corporate Update

globenewswire.com
BNTX

BioNTech Announces Appointment of Guido Oelkers to Management Board as Chief Executive Officer

globenewswire.com
BNTX

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

businesswire.com
BNTX PFE

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

globenewswire.com
PFE BNTX

Correction: Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight

globenewswire.com
JNJ BNTX GMAB IMUX INO PDSB AZN GSK MRK BIIB EXEL REGN CUE IOBT RAPT PRE

European Patent Office Confirms Patent Protection for SOT201, SOTIO's Clinical-Stage Immunocytokine Showing Promising Anti-Tumor Activity

globenewswire.com
BNTX

BioNTech to Report Second Quarter 2026 Financial Results and Corporate Update on August 4, 2026

globenewswire.com
BNTX

NCLA Urges Supreme Court to Hear Vaccine Mandate Case that Clearly Misreads Precedent

globenewswire.com
BNTX

Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and BioNTech, Receives First Payment From Moderna Settlement Agreement and Announces Intent to Return Capital to Shareholders

globenewswire.com
ABUS ROIV PFE BNTX MRNA